The Role of Platelets in the Advancement of Fatty Liver Disease Linked to Metabolic Dysfunction-Associated Steatohepatitis: A Review of Pathophysiological Mechanisms - Takeaways - MDSpire

The Role of Platelets in the Advancement of Fatty Liver Disease Linked to Metabolic Dysfunction-Associated Steatohepatitis: A Review of Pathophysiological Mechanisms

  • By

  • Naif M. Alhawiti

  • April 22, 2026

  • 0 min

Share

  • 1

    Metabolic dysfunction-associated steatohepatitis (MASH) can progress to cirrhosis and hepatocellular carcinoma if not managed properly.

  • 2

    Platelet activation is significantly correlated with MASH severity, inflammatory activity, and fibrotic progression.

  • 3

    Activated platelets contribute to liver injury through inflammatory mediators, oxidative stress, and coagulation dysfunction.

  • 4

    Therapeutic strategies targeting platelet activity may improve MASH treatment outcomes, but robust clinical evidence is needed.

  • 5

    Understanding the complex interactions between platelets and liver pathology is essential for developing personalized treatment strategies for MASH.

Original Source(s)

The Role of Platelets in the Advancement of Fatty Liver Disease Linked to Metabolic Dysfunction-Associated Steatohepatitis: A Review of Pathophysiological Mechanisms

  • by Naif M. Alhawiti

  • April 22, 2026

Related Content

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

An efficient pyramid scene parsing network with multi-scale feature fusion for liver segmentation in magnetic resonance imaging

Borderline Liver Enzyme Patterns and Their Metabolic–Inflammatory Signatures: An Observational Outpatient Study